Cole DE - Search Results

1

Pediatric phase I trial and pharmacokinetic study of topotecan administered as a 24-hour continuous infusion.

Blaney SM, Balis FM, Cole DE, Craig C, Reid JM, Ames MM, Krailo M, Reaman G, Hammond D, Poplack DG. Blaney SM, et al. Among authors: cole de. Cancer Res. 1993 Mar 1;53(5):1032-6. Cancer Res. 1993. PMID: 8439950 Clinical Trial.

2

Modulation of the cytotoxic effect of cyclopentenylcytosine by its primary metabolite, cyclopentenyluridine.

Blaney SM, Balis FM, Grem J, Cole DE, Adamson PC, Poplack DG. Blaney SM, et al. Among authors: cole de. Cancer Res. 1992 Jun 15;52(12):3503-5. Cancer Res. 1992. PMID: 1596909

3

Intrathecal administration of topotecan in nonhuman primates.

Blaney SM, Cole DE, Godwin K, Sung C, Poplack DG, Balis FM. Blaney SM, et al. Among authors: cole de. Cancer Chemother Pharmacol. 1995;36(2):121-4. doi: 10.1007/BF00689195. Cancer Chemother Pharmacol. 1995. PMID: 7767947

4

A pharmacokinetic model of topotecan clearance from plasma and cerebrospinal fluid.

Sung C, Blaney SM, Cole DE, Balis FM, Dedrick RL. Sung C, et al. Among authors: cole de. Cancer Res. 1994 Oct 1;54(19):5118-22. Cancer Res. 1994. PMID: 7923128

5

Plasma and cerebrospinal fluid pharmacokinetic study of topotecan in nonhuman primates.

Blaney SM, Cole DE, Balis FM, Godwin K, Poplack DG. Blaney SM, et al. Among authors: cole de. Cancer Res. 1993 Feb 15;53(4):725-7. Cancer Res. 1993. PMID: 8428353

6

Phase I/pharmacokinetic reevaluation of thioTEPA.

O'Dwyer PJ, LaCreta F, Engstrom PF, Peter R, Tartaglia L, Cole D, Litwin S, DeVito J, Poplack D, DeLap RJ, et al. O'Dwyer PJ, et al. Cancer Res. 1991 Jun 15;51(12):3171-6. Cancer Res. 1991. PMID: 1710167 Clinical Trial.

7

Phase I clinical trial of intrathecal topotecan in patients with neoplastic meningitis.

Blaney SM, Heideman R, Berg S, Adamson P, Gillespie A, Geyer JR, Packer R, Matthay K, Jaeckle K, Cole D, Kuttesch N, Poplack DG, Balis FM. Blaney SM, et al. J Clin Oncol. 2003 Jan 1;21(1):143-7. doi: 10.1200/JCO.2003.04.053. J Clin Oncol. 2003. PMID: 12506183 Clinical Trial.

8

Phase I and pharmacokinetic evaluation of thiotepa in the cerebrospinal fluid and plasma of pediatric patients: evidence for dose-dependent plasma clearance of thiotepa.

Heideman RL, Cole DE, Balis F, Sato J, Reaman GH, Packer RJ, Singher LJ, Ettinger LJ, Gillespie A, Sam J, et al. Heideman RL, et al. Among authors: cole de. Cancer Res. 1989 Feb 1;49(3):736-41. Cancer Res. 1989. PMID: 2491958

9

Mechanism of resistance to cyclopentenyl cytosine (CPE-C) in Molt-4 lymphoblasts.

Blaney SM, Grem JL, Balis FM, Cole DE, Adamson PC, Poplack DG. Blaney SM, et al. Among authors: cole de. Biochem Pharmacol. 1993 Apr 6;45(7):1493-501. doi: 10.1016/0006-2952(93)90050-7. Biochem Pharmacol. 1993. PMID: 8471071

10

Plasma and cerebrospinal fluid pharmacokinetics of 9-aminocamptothecin (9-AC), irinotecan (CPT-11), and SN-38 in nonhuman primates.

Blaney SM, Takimoto C, Murry DJ, Kuttesch N, McCully C, Cole DE, Godwin K, Balis FM. Blaney SM, et al. Among authors: cole de. Cancer Chemother Pharmacol. 1998;41(6):464-8. doi: 10.1007/s002800050768. Cancer Chemother Pharmacol. 1998. PMID: 9554590

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

337 results

Search Page

Filters